Prescribing overview
An injectable sedative with muscle-relaxant and analgesic effects. Species and route depend on the specific product.
Sedation does not ensure adequate analgesia or prevent kicking. Choose an appropriate procedure, quiet handling environment and recovery plan, and reassess pain response before proceeding. Cardiovascular and respiratory effects require professional supervision.
Key prescribing checks
- Review the source-specific safety card and monitoring plan before use.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Horses
U.S. labeled/regulatory equine use; see exact scopeProcedural sedation; Rompun labeling also describes shorter analgesia and specified Cervidae uses
AnaSed Equine: horses. Rompun: horses, fallow deer, mule deer, sika deer, white-tailed deer and elk; product-specific restrictions apply.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Alpha-2 receptor activity reduces central norepinephrine release. Sedation, analgesia and muscle relaxation have different duration and clinical intensity.
Absorption, distribution, metabolism and elimination
The reviewed labels describe route-dependent onset and clinical duration rather than a complete species-specific clearance model. These timing descriptions are not redosing instructions.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
AnaSed Equine / Rompun
Selected U.S. AnaSed Equine and Rompun labels; not every xylazine formulation.
Contraindications · when not to use
- AnaSed Equine labeling says not to combine with neuroleptics or tranquilizers.
Precautions & monitoring
- Cardiac, respiratory, hepatic or renal disease, shock and debilitation warrant careful assessment and monitoring.
- Do not use in food-chain horses. Rompun includes Cervidae hunting-season and recovery restrictions; pregnancy safety in Cervidae is unestablished.
This is a selected source summary, not exhaustive prescribing guidance.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Bradycardia, AV block, reduced respiratory rate, sweating and tremors may occur. Accidental intra-arterial administration can cause seizures and collapse.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
No numerical regimen is reproduced. Verify species, concentration, route, prior sedation and the exact current product label.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Compare with other medications and check species →
AnaSed Equine / Rompun
Selected U.S. AnaSed Equine and Rompun labels; not every xylazine formulation.
- CNS depressants, including barbiturates, have additive effects; anesthetic requirements may be reduced.
Monitoring
Observe heart rhythm, respiration, standing stability and response to stimulation throughout the procedure and recovery.
Client counseling
Keep the environment quiet and follow recovery instructions. Avoid human exposure; seek urgent medical advice after self-injection and do not drive.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Observe the exact vial’s temperature and first-puncture limits; AnaSed and Rompun instructions differ.
Brands, formulations & ingredient identity
Active ingredients
Xylazine hydrochloride
Other searchable names: AnaSed · AnaSed Equine · Rompun
AnaSed Equine is an equine product; the reviewed Rompun label additionally names specified Cervidae. This does not establish approval in all deer species or domestic ruminants.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
AnaSed Equine
- Formulation
- Xylazine injection
- Label / product scope
- Horses
Equine product; IV or IM.
Product label / source ↗Rompun
- Formulation
- Xylazine injection
- Label / product scope
- Horses · Fallow deer · Mule deer · Sika deer · White-tailed deer · Elk
Specified Cervidae only; horse and Cervidae routes differ.
Product label / source ↗References & review status
Clinical reference updated October 27, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
Search another medication or supplement →